Ligustri-Astragali Casein Co-Peptide Serum Inhibition of Human Lung Adenocarcinoma A549 Cells and its Mechanicsm Study

ZHANG Yan-yin1; WU Jian-jun1; WANG Peng-shan2; XUE Na1; SHU Chang1; WU Hong-yan1

doi:10.13422/j.cnki.syfjx.2010.04.045

您当前的位置：

首页 >

文章列表页 >

Ligustri-Astragali Casein Co-Peptide Serum Inhibition of Human Lung Adenocarcinoma A549 Cells and its Mechanicsm Study

更新时间：2024-09-23

- Ligustri-Astragali Casein Co-Peptide Serum Inhibition of Human Lung Adenocarcinoma A549 Cells and its Mechanicsm Study
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 16, Issue 4, Pages: 114-117(2010)
- 作者机构：
  
  1. 甘肃中医学院
  2. 高台县宣化乡卫生院
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2010.04.045
  CLC： R285.5
- Published：2010
- 稿件说明：
移动端阅览
[1]张延英,吴建军,王鹏善,薛娜,舒畅,吴红彦.贞芪酪蛋白肽复合物血清对人肺腺癌A549细胞分化抑制作用及相关机制研究[J].中国实验方剂学杂志,2010,16(04):114-117.

ZHANG Yan-yin1, WU Jian-jun1, WANG Peng-shan2, et al. Ligustri-Astragali Casein Co-Peptide Serum Inhibition of Human Lung Adenocarcinoma A549 Cells and its Mechanicsm Study[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(4): 114-117.
[1]张延英,吴建军,王鹏善,薛娜,舒畅,吴红彦.贞芪酪蛋白肽复合物血清对人肺腺癌A549细胞分化抑制作用及相关机制研究[J].中国实验方剂学杂志,2010,16(04):114-117. DOI： 10.13422/j.cnki.syfjx.2010.04.045.

ZHANG Yan-yin1, WU Jian-jun1, WANG Peng-shan2, et al. Ligustri-Astragali Casein Co-Peptide Serum Inhibition of Human Lung Adenocarcinoma A549 Cells and its Mechanicsm Study[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(4): 114-117. DOI： 10.13422/j.cnki.syfjx.2010.04.045.

摘要

目的:探索贞芪酪蛋白肽（ligustri-astragali casein co-peptid

LACP）复合物对人肺腺癌A549细胞分化的诱导作用及作用机制。方法:MTT法检测贞芪酪蛋白肽含药血清5%

10%

15%

20%浓度对人肺腺癌A549细胞增殖的影响;通过贞芪酪蛋白肽药物血清对A549细胞核质比和端粒酶活性的影响观察其诱导分化作用;免疫细胞化学方法观察贞芪酪蛋白肽药物血清对A549细胞Bax/bcl-2基因表达的影响。结果:4种不同浓度的贞芪酪蛋白肽含药血清均对A549细胞增殖有抑制作用

其中以浓度为20%的贞芪酪蛋白肽血清的抑制率最高;能降低细胞的核质比

并抑制人肺癌细胞端粒酶活性的作用;贞芪酪蛋白肽血清能促进A549细胞凋亡基因bax/bcl-2的表达

与无药血清对照组比较

差异有统计学意义（P<0.01）。结论:贞芪酪蛋白肽含药血清对人肺腺癌细胞A549有一定抑制作用;有诱导人肺癌细胞A549分化的作用

其主要机理可能是抑制了A549细胞端粒酶活性;贞芪酪蛋白肽诱导A549细胞凋亡的作用机制之一可能是促进促凋亡基因bax/bcl-2的表达。

Abstract

Objective:To explore the effect of ligustri-astragali casein co-peptid（LACP） on human lung adenocarcinoma A549 cell differentiation and the related mechanism.Method: MTT assay for human lung adenocarcinoma A549 cells;containing 5%

10%

15%

20% concentration of LACP serum was used.The influence of LACP containing serum on differentiation was evaluated by investigation of cellular nuclear-mass ratio and telomerase activity.Immunocytochemical method was used to observe the effect of LACP drug serum on the A549 Bax /bcl-2 expression.Results: The four kinds of different concentrations of LACP serum inhibited A549 cell proliferation.Among them

20% of LACP showed the highest inhibitory rate;and reduced the cell’s nuclear-mass ratio.LACP serum promoted A549 cell bax / bcl-2 gene expression for apoptosis

and compared with the serum-free control group

the difference was significant（P < 0.05）.Conclusion: LACP containing serum has certain inhibitory effect on human lung adenocarcinoma A549 cells.LACP complex shows promotion to human lung cancer cell A549 differentiation.The mechanism may be linked to inhibition of telomerase activity.The complex induced apoptosis of A549 cells may be related to promotion of bax /bcl-2 gene expression.

关键词

Keywords

references

Views

165

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Ligustri-Astragali Casein Co-Peptide Serum Inhibition of Human Lung Adenocarcinoma A549 Cells and its Mechanicsm Study

Treatment of Sepsis-induced Inflammatory Responses with Xijiao Dihuangtang by Modulation of PKM2-mediated One-carbon Metabolism Pathway

Mitochondrial Quality Control Regulating Pathogenesis of Sarcopenia and Its Intervention by Traditional Chinese Medicine： A Review

Mechanism of Modified Danggui Shaoyaosan in Improving Inflammation and Apoptosis in Acne via Regulating JNK/p38 MAPK Pathway

Programmed Cell Death in Endometriosis and Traditional Chinese Medicine Intervention： A Review

Related Author

ZHANG Yan-yin

WU Jian-jun

WANG Peng-shan

XUE Na

SHU Chang

WU Hong-yan

YAN Qixiang

ZHU Yeyan

Related Institution

Affiliated Hospital of Nanjing University of Chinese Medicine

The First Clinical Medical College，Nanjing University of Chinese Medicine

Jiangsu Province Hospital of Chinese Medicine

The First Affiliated Hospital of Henan University of Chinese Medicine

The First Clinical Medical School of Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰